Indian Drug Makers Find New EU Rule Requires DCGI Quality Certification
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers are challenging a European Union rule that requires active pharmaceutical ingredients be backed by Indian regulatory certification as to their quality and compliance with GMP standards.